Filing Details
- Accession Number:
- 0001104659-16-140757
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-19 19:26:02
- Reporting Period:
- 2016-08-19
- Filing Date:
- 2016-08-19
- Accepted Time:
- 2016-08-19 19:26:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1297184 | Amphastar Pharmaceuticals Inc. | AMPH | Pharmaceutical Preparations (2834) | 330702205 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1611283 | G. Diane Gerst | C/O Amphastar Pharmaceuticals, Inc. 11570 6Th Street Rancho Cucamonga CA 91730 | Evp, Qa & Regulatory Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-08-19 | 10,046 | $14.23 | 39,031 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-08-19 | 14,000 | $10.93 | 53,031 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-08-19 | 24,046 | $19.28 | 28,985 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2016-08-19 | 10,046 | $0.00 | 10,046 | $14.23 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2016-08-19 | 14,000 | $0.00 | 14,000 | $10.93 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,954 | 2021-12-22 | No | 4 | M | Direct | |
| 14,000 | 2023-07-30 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2016.
- Shares subject to the option are fully vested and immediately exercisable.
Billionaire Hedge Funds
